Latest Capital Equipment News

A single diagnostics update sparked a breakout week, while a handful of biotech names sold off hard despite busy newsflow. Capital raisings, takeover steps and US market pushes kept healthcare in motion heading into mid-February milestones.

Trajan Group Holdings reports a mixed first half for FY26 with soft Q1 performance but a strong Q2 rebound, maintaining full-year guidance amid tariff and cost pressures.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

CONNEQT Health has reported a remarkable surge in Pulse device sales, exceeding 200% growth quarter-on-quarter, while advancing its transition to a recurring revenue model through enterprise contracts and consumer subscriptions.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its NorthStar Mapping System, the first MRI-native 3D cardiac mapping platform approved in the US. This approval positions Imricor at the forefront of MRI-guided cardiac procedures in the world’s largest electrophysiology market.

Imricor Medical Systems has achieved multiple world-first procedures using real-time MRI guidance for cardiac ablation, advancing clinical trials and regulatory progress amid a strategic commercial expansion.

Australian Dairy Nutritionals Limited (AHF) is raising approximately $3.47 million through a pro-rata entitlement offer to accelerate its growth plans in China and enhance processing efficiency.

Amaero Ltd has lowered its FY2026 revenue guidance due to delayed U.S. government contracts but reports strong contracted revenue and a robust cash position heading into 2026.

Celsius Resources has postponed the final Feasibility Study for its Maalinao-Caigutan-Biyog Copper-Gold Project to January 2026, while engaging a top financial advisory firm to secure project financing amid strong international interest.

XRF Scientific has reported a robust September quarter with a 16% increase in revenue, driven by strong international sales and new product launches. The company is poised for further expansion with ongoing innovation and strategic focus on global markets.

Vault Minerals projects steady gold production in FY26 with growth through FY28, driven by key plant upgrades and the anticipated restart of Sugar Zone operations. The company plans significant capital and exploration investments while preparing to fully unwind its hedge book.

Trajan Holdings delivered solid FY2025 results with revenue up 7.4% to $166.5 million and improved profitability despite transient costs and a biotech syringe loss. The company refinanced debt and set an optimistic FY2026 guidance range.